Shiba Jhawar
Cardiovascular Disease · Enfield, CTNPI 1629042973
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 34.4% of the total. Reporting peaked in 2019 at $1,423 and has fallen 75.2% since, to $354 in 2022.
Across 129 payments — averaging $27.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- AstraZeneca$1K
- Pfizer$358
- E.r. Squibb & Sons, L.L.C.$194
- Novartis$170
- Abbott$139
- plus $463 from 9 others
What the payments were for
- Food & beverage$3,566100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 50 | $1,225 |
| AstraZeneca | 26 | $1,017 |
| Pfizer | 20 | $358 |
| E.r. Squibb & Sons, L.L.C. | 6 | $194 |
| Novartis | 4 | $170 |
| Abbott | 3 | $139 |
| Boehringer Ingelheim | 2 | $134 |
| Lilly USA, LLC | 5 | $98 |
| Merck | 3 | $52 |
| Amarin Pharma, Inc. | 3 | $46 |
| Astellas Pharma US Inc | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Novo Nordisk | 1 | $25 |
| Sanofi | 1 | $24 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$585
- XARELTO$467
- FreeStyle Libre$118
- ENTRESTO$113
- JARDIANCE$112
How this compares
$3,566 in reported general payments places this provider in the 70th percentile of 415 cardiovascular disease providers in Connecticut.
Other cardiovascular disease in Enfield
- Nihar DesaiNew Haven$1.4M
- Brett NowlanBloomfield$798K
- Jeffery TestaniNew Haven$546K
- Carlos Mena-HurtadoNew Haven$460K
- Stephanie SaucierHartford$243K
- John ForrestNew Haven$164K
- Henry WardNew Haven$152K
- Ricardo CordidoHamden$135K
- Antonio FernandezHartford$113K
- Paul ThompsonHartford$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.